Your browser doesn't support javascript.
loading
CCAT2 contributes to progression and treatment resistance of thyroid carcinoma.
Fu, W; Wang, X-D; Ye, J-D; Jin, J; Chen, L; Qi, Q-Y.
Affiliation
  • Fu W; Department of Thyroid and Breast Surgery, The Ninth People's Hospital of Suzhou, Suzhou, China. qiqingyi@163.com.
Eur Rev Med Pharmacol Sci ; 24(23): 12224-12231, 2020 12.
Article in En | MEDLINE | ID: mdl-33336741
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / RNA, Long Noncoding / Thyroid Carcinoma, Anaplastic / Thyroid Cancer, Papillary Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / RNA, Long Noncoding / Thyroid Carcinoma, Anaplastic / Thyroid Cancer, Papillary Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country: